Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 3.480
-0.130 (-3.60%)
Aug 14, 2026, 5:24 PM CET
Boule Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 461.29 | 489.69 | 558.46 | 571.33 | 548.09 | 463.34 | |
Revenue Growth | -10.58% | -12.31% | -2.25% | 4.24% | 18.29% | 15.70% |
Cost of Revenue | 262.98 | 275.88 | 303.33 | 321.62 | 320.18 | 264.71 |
Gross Profit | 198.31 | 213.81 | 255.13 | 249.71 | 227.91 | 198.64 |
Selling, General & Admin | 124.44 | 129.64 | 146.89 | 153.35 | 143.6 | 120.15 |
Research & Development | 52.8 | 40.4 | 37.8 | 53.09 | 51.57 | 43.33 |
Other Operating Expenses | -5.74 | -2.44 | 6.62 | - | -0.74 | -0.7 |
Operating Expenses | 171.5 | 167.6 | 191.31 | 206.44 | 194.43 | 162.78 |
Operating Income | 26.81 | 46.21 | 63.82 | 43.27 | 33.48 | 35.86 |
Interest Expense | -15.38 | -15.88 | -12.49 | -11.3 | -9.85 | -5.49 |
Interest & Investment Income | 0.52 | 1.52 | 1.39 | 1.14 | 1.78 | 1.35 |
Currency Exchange Gain (Loss) | -0.15 | -0.15 | 0.15 | -3.01 | -4.5 | -2.95 |
Other Non Operating Income (Expenses) | 0.1 | - | -0.1 | 0 | -0 | -0 |
EBT Excluding Unusual Items | 11.9 | 31.7 | 52.77 | 30.1 | 20.9 | 28.77 |
Merger & Restructuring Charges | 0.03 | -18.47 | -22.8 | - | - | - |
Gain (Loss) on Sale of Assets | -0.4 | -0.4 | - | - | -0.05 | - |
Asset Writedown | -8.42 | -6.92 | -390.72 | - | - | - |
Pretax Income | 3.11 | 5.91 | -360.75 | 30.1 | 20.85 | 28.77 |
Income Tax Expense | 5.86 | 9.66 | -64.17 | 5.12 | 8.12 | 5.5 |
Net Income | -2.75 | -3.75 | -296.58 | 24.98 | 12.73 | 23.27 |
Net Income to Common | -2.75 | -3.75 | -296.58 | 24.98 | 12.73 | 23.27 |
Net Income Growth | - | - | - | 96.24% | -45.31% | - |
Shares Outstanding (Basic) | 35 | 39 | 39 | 39 | 28 | 27 |
Shares Outstanding (Diluted) | 35 | 39 | 39 | 39 | 28 | 27 |
Shares Change | -15.97% | - | - | 36.37% | 4.65% | 40.14% |
EPS (Basic) | -0.08 | -0.10 | -7.64 | 0.64 | 0.46 | 0.87 |
EPS (Diluted) | -0.08 | -0.10 | -7.64 | 0.64 | 0.45 | 0.86 |
EPS Growth | - | - | - | 42.22% | -47.67% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 18.44 | -2.66 | 37.68 | 44.51 | -17.79 | 40.14 |
Free Cash Flow Per Share | 0.52 | -0.07 | 0.97 | 1.15 | -0.63 | 1.48 |
Dividend Per Share | - | - | - | - | - | 0.550 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 42.99% | 43.66% | 45.68% | 43.71% | 41.58% | 42.87% |
Operating Margin | 5.81% | 9.44% | 11.43% | 7.57% | 6.11% | 7.74% |
Profit Margin | -0.60% | -0.77% | -53.11% | 4.37% | 2.32% | 5.02% |
Free Cash Flow Margin | 4.00% | -0.54% | 6.75% | 7.79% | -3.25% | 8.66% |
EBITDA | 21.65 | 49.95 | 67.98 | 60.41 | 54.14 | 51.17 |
EBITDA Margin | 4.69% | 10.20% | 12.17% | 10.57% | 9.88% | 11.04% |
D&A For EBITDA | -5.16 | 3.74 | 4.16 | 17.14 | 20.66 | 15.31 |
EBIT | 26.81 | 46.21 | 63.82 | 43.27 | 33.48 | 35.86 |
EBIT Margin | 5.81% | 9.44% | 11.43% | 7.57% | 6.11% | 7.74% |
Effective Tax Rate | 188.49% | 163.49% | - | 17.02% | 38.95% | 19.11% |